Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
High cholesterol can raise the risk of heart attack and stroke, so patients should not stop prescribed medicine without medical advice
Patients must be at least 18 years old and meet one of the following clinical requirements when GLP-1 therapy begins: A body mass index, or BMI, of 35 or higher A BMI between 30 and 34.99 with at least one qualifying health condition A BMI between 27 and 29.99 with at least one qualifying higher-risk health condition For someone with a BMI between 30 and 34.99, qualifying conditions may include heart failure with preserved ejection fraction, uncontrolled high blood pressure, stage 3a or higher chronic kidney disease, prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
Singh AK et al
GLP-1 medications like semaglutide and tirzepatide, commonly prescribed for weight loss and type 2 diabetes, are transforming how we think about metabolic health
US$ 25.89
US$ 22.63
US$ 22.16
US$ 26.71
US$ 29.94
